Laboratorios Farmaceuticos ROVI SA :For 2022, Rovi Expects Its Operating Revenue To Increase Between 15% And 20%.Forecasts That It Will Continue To Grow At A Much Higher Rate Than The Spanish Pharmaceutical Market Expenditure In The First Five Months Of 2022.